AIQ Solutions will be attending Immuno-Oncology 360° from February 23rd through 26th, 2021 in a virtual format. Request a meeting to learn more about AIQ Solutions, and our treatment response quantification and prediction technology.

AIQ's software has been cleared for clinical use under 510(k) K173444. For details, including the applicable Indications for Use,
see: https://www.accessdata.fda.gov/scripts/cdrh/cfcodes/cfPMN/pmn.cfm?ID=K173444